Impact of a clinical solid organ transplant pharmacist on tacrolimus nephrotoxicity, therapeutic drug monitoring, and institutional revenue generation in adult kidney transplant recipients

Progress in Transplantation

Volumn 26, Issue 4, 2016, Pages 314-321

  Griffin, Shawn P ^a   Nelson, Joelle E ^a,b,c  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Kidney transplantation; Nephrotoxicity; Pharmacist; Pharmacy; Tacrolimus

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; DRUG MONITORING; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; MALE; PHARMACIST; PROFESSIONAL STANDARD; RETROSPECTIVE STUDY;

ADULT; DRUG MONITORING; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; PHARMACISTS; PROFESSIONAL ROLE; RETROSPECTIVE STUDIES; TACROLIMUS; TRANSPLANT RECIPIENTS;

EID: 85014418254     PISSN: 15269248     EISSN: 21646708     Source Type: Journal    
DOI: 10.1177/1526924816667950     Document Type: Article

References (15)

1. Hart A, Smith JM, Skeans MA, et al. OPTN/SRTR 2014 annual data report. Am J Transplant. 2016;16(S2):11-46.
2. Stemer G, Lemmens-Gruber R. Clinical pharmacy services and solid organ transplantation: a literature review. Pharm World Sci. 2010;32(1):7-18. doi:10.1007/s11096-009-9351-7.
3. Musgrave CR, Pilch NA, Taber DJ, et al. Improving transplant patient safety through pharmacist discharge medication reconciliation. Am J Transplant. 2013;13(3):796-801. doi:10.1111/ajt.12070.
4. Taber DJ, Pilch NA, McGillicuddy JW, Bratton CF, Chavin KD, Baliga PK. Improved patient safety and outcomes with a comprehensive interdisciplinary improvement initiative in kidney transplant recipients. Am J Med Qual. 2013;28(2):103-112. doi: 10.1177/1062860612450309.
5. Maldonado AQ, Weeks DL, Bitterman AN, et al. Changing transplant recipient education and inpatient transplant pharmacy practices: a single-center perspective. Am J Health Syst Pharm. 2013;70(1):900-904. doi:10.2146/ajhp120254.
6. Jacobson PA, Schladt D, Israni A, et al; DeKAF Investigators. Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium. Transplantation. 2012;93(6):624-631. doi:10.1097/TP.0b013e3182461288.
7. Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009;4(2):481-508. doi:10.2215/CJN.04800908.
8. Schiff J, Cole E, Cantarovich M. Therapeutic monitoring of calcineurin inhibitors for the nephrologist. Clin J Am Soc Nephrol. 2007;2(2):374-384.
9. Ye ZK, Tang HL, Zhai SD. Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis. PLoS One. 2013;8(10):e77169. doi:10.1371/journal.pone.0077169.
10. Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66(1):82-98. doi:10.2146/ajhp080434.
11. Kellum JA, Lameire N, Aspelin P, et al. KDIGO clinical practice guidelines for acute kidney injury. Kidney Int. 2012;2(1):1-138. doi:10.1038/kisup.2012.1.
12. Siedlecki A, Irish W, Brennan DC. Delayed graft function in the kidney transplant. Am J Transplant. 2011;11(11):2279-2296. doi:10.1111/j.1600-6143.2011.03754.x.
13. Machnicki G, Lentine KL, Salvalaggio PR, Burroughs TE, Brennan DC, Schnitzler MA. Kidney transplant Medicare payments and length of stay: associations with comorbidities and organ quality. Arch Med Sci. 2011;7(2):278-286. doi:10.5114/aoms.2011.22079.
14. Locke JE, Segev DL, Warren DS, Dominici F, Simpkins CE, Montgomery RA. Outcomes of kidneys from donors after cardiac death: implications for allocation and preservation. Am J Transplant. 2007;7(7):1797-1807.
15. Hanaway MJ, Woodle ES, Mulgaonkar S, et al; INTAC Study Group. Alemtuzumab induction in renal transplantation. N Engl J Med. 2011;364(20):1909-1919. doi:10.1056/NEJMoa1009546.